[New perspective in the medical management of primary hyperparathyroidism].
Most of the medical proposed for patients with primary hyperparathyroidism are inefficient or dangerous, with the exception of oestrogens and physiological doses of vitamin D in selected cases. PTH analogs, calcimimetic drugs and anti-PTH immunization now provide attractive management perspectives.